Tetrahydrofuran lignans represent a well-known group of phenolic compounds capable of acting as antiparasitic agents. In the search for new medicines for the treatment of Chagas disease, one promising compound is grandisin which has shown significant activity on trypomastigote forms of Trypanosoma cruzi. In this work, the in vitro metabolism of grandisin was studied in the pig cecum model and by biomimetic phase I reactions, aiming at an ensuing a preclinical pharmacokinetic investigation. Although grandisin exhibited no metabolization by the pig microbiota, one putative metabolite was formed in a biomimetic model using Jacobsen catalyst. The putative metabolite was tested against T. cruzi revealing loss of activity in comparison to grandisin.
Key words tetrahydrofuran lignans · grandisin · in vitro metabolism · Piper solmsianum · Piperaceae · Jacobsen catalyst Abbreviations ! CYP450: cytochrome P450 Mn(salen): Jacobsen catalyst Supporting information available online at http://www.thieme-connect.de/ejournals/toc/plantamedica There are few studies on intestinal and phase I metabolites of natural products [1] [2] [3] . During the last years the "pig cecum model" was developed and further improved, showing good results for the metabolization of phenolic compounds [4] [5] [6] [7] [8] [9] [10] . For phase I metabolism, several in vitro biomimetic models were developed, while Mn(salen) appeared as an alternative to produce similar metabolites of CYP450 enzymes [11, 12] yielding a putative metabolite in a good scale [13, 14] . Previous investigations of the trypanocidal activity of tetrahydrofuran lignans showed several significant results [15] [16] [17] which were already registered as a patent [18] . Chagas disease affects more than 10 million people in the world and is concentrated in Latin America where it has an impact on the medical health system [19] . In this context, the aim of this work was to investigate the metabolism of grandisin in the pig cecum model by applying biomimetic reactions in order to improve information on its preclinical pharmacokinetic and also on the biological activity of the putative metabolite. Under the chosen experimental conditions, no metabolization of grandisin was observed in the pig cecum model. Even though there are some studies showing fungal grandisin metabolism [20] and metabolism of lignans from flax by intestinal bacteria [21] , the yield was very low and apparently the bacteria from the pig intestinal tract were not able to metabolize this lignan. The high recovery value observed in addition to the control metabolization using quercetin eliminates any possibility of technical problems. This result indicates high intestinal stability of grandisin, which is one prerequisite for good absorption in an oral administration. Recently, the biotransformation of grandisin by rat liver microsomes showed a dehydro metabolite [22] suggesting that a possible oxidized metabolite may be formed by liver phase I reactions. To confirm this proposition, we applied a biomimetic oxidation of grandisin catalyzed by Mn(salen). The results demonstrate the presence of two products, a minor signal resulting from the oxidative cleavage of grandisin, as previously observed for caterpillarsʼ metabolism [23] . A second product was isolated by TLC and characterized as dehydro-grandisin: 3,4-dimethyl-2,5-bis(3,4,5-trimethoxyphenyl)-2,3-dihydrofuran (2) (l " Fig. 1 ). The ESI-HRMS spectrum showed the [M + H] + signal at m/z 431.2064, confirming the molecular formula as the same as observed for the product obtained after metabolization by liver microsomes [22] . The putative metabolite was submitted to 1 H NMR analysis, and the data was compared to grandisin. Grandisin has trans,trans,trans relative stereochemistry, so that the oxybenzylic and methynic protons are equivalent. In contrast, the putative metabolite lost this symmetry and appeared as two sets of signals with similar chemical shifts at δ H 6.67 and δ H 6.58 ppm for the aromatic protons H-2/H-6 and H-2′/H-6′, respectively. The same effect was observed for the -OCH 3 singlets confirming the symmetry loss and that no reaction occurred in any aromatic ring. The major difference was observed for the positions H-7/H-7′ and H-8/H-8′. The integration of the well-defined signals at δ H 4.80 (H-7′, d, J = 8.6 Hz) and at δ H 2.91 (H-8′, m) allowed to determine the occurrence of one proton per peak and also a deshielding effect in relation to the signals from grandisin [23] . The same deshielded effect was observed for the methyl protons at C-9 (1.84 d, J = 1.4 Hz). Finally, to confirm the stereochemistry of de- hydro-grandisin, the CD spectra were recorded for the metabolite and grandisin. Both spectra showed two similar bands, one centered at about 208 (positive) and other at 243 nm (negative) for grandisin and the metabolite, proving that they have the same configuration (R,R) [24] . The final step was to define if the putative metabolite still had biological activity as observed with grandisin against the trypomastigote form of T. cruzi [2] . After isolation, dehydro-grandisin was evaluated against this parasite. The absence of activity indicates that the opposite spacial geometry of rings and methyl groups is important in the grandisin molecule to show an effect against this parasite.
Materials and Methods

!
Piper solmsianum C. DC. was collected in Ubatuba (São Paulo, Brazil) and identified by Dr. Elci Franklin Guimarães (Jardim Botâni-co do Rio de Janeiro, Brazil) where a voucher specimen (329676) is deposited. This work was carried out with the CGEN license number 005/2009. Dried and pulverized leaves were extracted as previously described, and (−)grandisin (98%, determined by GC-MS) was obtained [25] . (−)Grandisin was assayed in the pig cecum model and the Mn (salen) oxidation procedure as reported before. The putative metabolite obtained using Mn(salen) was assayed against T. cruzi in a specific and sensitive test [26] . For a description of these methods, see Supporting Information. 
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